OptimizeRx Reports First Quarter 2024 Financial Results
Management believes that these non-GAAP financial measures provide additional insight into the operations and cash flow of the Company.
- Management believes that these non-GAAP financial measures provide additional insight into the operations and cash flow of the Company.
- The Company’s non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in the Company’s industry, as other companies in the industry may calculate such non-GAAP financial results differently.
- The Company does not consider these non-GAAP measures to be substitutes for or superior to the information provided by its GAAP financial results.
- The table, “Reconciliation of Non-GAAP to GAAP Financial Measures,” included below, provides a reconciliation of Non-GAAP net loss, Non-GAAP EPS and Adjusted EBITDA for the three months ended March 31, 2024 and 2023.